ABSTRACT Introduction: Antiepileptic drugs (AEDs) are the cornerstone of treatment of
patients with epilepsy, and there are presently 27 licensed AEDs making AEDs among the …

Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …

Background and objective Laboratories sometimes use different reference ranges for the
same antiepileptic drug (AED), particularly for new and poorly investigated drugs. This may …

Objective Perampanel is one of the most recently approved antiseizure medications. The
aim of the present study was to assess clinical efficacy and tolerability, in combination with …

Background This retrospective, observational study used US claims data to assess retention
rates on cenobamate compared with four branded antiseizure medications (ASMs) in …

Purpose Brivaracetam (BRV) is one of our latest antiseizure medications (ASMs). It is an
analogue of levetiracetam with limited real-life experience. The purpose of this study was to …

Introduction Epilepsy represents the third most common neurological disorder in the elderly.
Antiseizure medications (ASMs) are often used not only to treat epilepsy but also other …

The incidence of epilepsy is highest in the older adult age group. Seizures in older adults
can be more difficult to diagnose because their presentation is often subtle and can easily …

Human arylacetamide deacetylase (AADAC) plays a role in the detoxification or activation of
drugs and is sometimes involved in the incidence of toxicity by catalyzing hydrolysis …

Objective To examine the frequency of hyponatremia and potentially related symptoms in
clinical trials of eslicarbazepine acetate (ESL) in adults with focal‐(partial‐) onset seizures …